Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis

Sponsor
Nuvo Research Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00108992
Collaborator
(none)
750
22
19
34.1
1.8

Study Details

Study Description

Brief Summary

Oral non-steroidal anti-inflammatory drugs (NSAIDs) are a recommended treatment for the symptoms of osteoarthritis of the knee. However, NSAIDs may cause a range of negative side effects, including stomach pain, heartburn, bleeding stomach ulcer, and liver or kidney abnormality. A topical NSAID may relieve pain and other symptoms of osteoarthritis of the knee, while minimizing the side effects common to oral NSAIDs. The purpose of this study is to determine the safety and effectiveness of a topical NSAID when used alone or when combined with an oral NSAID in the treatment of osteoarthritis of the knee.

Condition or Disease Intervention/Treatment Phase
  • Drug: Diclofenac, topical
Phase 3

Detailed Description

During this 12-week study, patients will visit the study clinic 5 times. At the screening visit, the patient's demographic information, medical and medication history will be recorded and a physical examination performed. After washout of all NSAIDs/other analgesic medication, the patient will return for the baseline visit. During the treatment phase of the study, the patient will apply a topical solution to his/her osteoarthritic knee and take an oral study tablet. The patient may randomly receive active treatment with topical diclofenac, oral diclofenac, both, or neither (placebo). Follow-up clinic visits are conducted at 4, 8 and 12 weeks. Routine laboratory analyses are done at baseline, 4 and 12 weeks.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Study Start Date :
Feb 1, 2004
Study Completion Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

  1. pain []

  2. physical function []

  3. patient overall health assessment []

Secondary Outcome Measures

  1. stiffness []

  2. patient global assessment []

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary osteoarthritis of the knee, verified radiographically

  • Moderate flare of pain in the knee after washout of stable therapy

  • If female, non-pregnant

  • Ability to swallow moderately-sized tablets

Exclusion Criteria:
  • Secondary osteoarthritis of the knee

  • Major knee surgery at any time, or minor knee surgery in previous year

  • Severe uncontrolled heart, liver or kidney disease

  • Ulcer or bleeding from the stomach

  • Corticosteroid use

  • Fibromyalgia

  • Skin disorder of the knee

Contacts and Locations

Locations

Site City State Country Postal Code
1 Coastal Clinical Research Mobile Alabama United States 36608
2 Redpoint Research Phoenix Arizona United States 85029
3 OMC Clinical Beverly Hills California United States 90211
4 Associated Pharmaceutical Research Buena Park California United States 90620
5 Med Investigators Fair Oaks California United States 95628
6 Desert Medical Advances Palm Desert California United States 92260
7 Boling Clinical Trials Upland California United States 91786
8 Tampa Bay Medical Research Inc. Clearwater Florida United States 33761
9 Palm Beach Research Center West Palm Beach Florida United States 33409
10 Medisphere Medical Research Evansville Indiana United States 47714
11 Synergy Medical Education Alliance Saginaw Michigan United States 48602
12 Redrock Research Center Las Vegas Nevada United States 89146
13 Partners in Primary Care Voorhees New Jersey United States 08043
14 Camp Hill Clinical Research Center Camp Hill Pennsylvania United States 17011
15 Primary Physicians Research Pittsburgh Pennsylvania United States 15241
16 University Orthopedics Center State College Pennsylvania United States 16801
17 Omega Medical Research Warwick Rhode Island United States 02886
18 Clinical Research Associates Nashville Tennessee United States 37203
19 Research Across America Dallas Texas United States 75234
20 Sam Clinical Research Center San Antonio Texas United States 78229
21 Hamptom Roads Center for Clinical Research Norfolk Virginia United States 23502-9921
22 National Clinical Research Richmond Virginia United States 23294

Sponsors and Collaborators

  • Nuvo Research Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00108992
Other Study ID Numbers:
  • PEN-03-112
First Posted:
Apr 22, 2005
Last Update Posted:
Jan 5, 2007
Last Verified:
Jan 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2007